GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
  • Reports
    • GHTM
    • Scientific Advisory Board
    • FCT
Home / Articles / GHTM/IHMT-NOVA’s researchers attended the 33rd ECCMID

GHTM/IHMT-NOVA’s researchers attended the 33rd ECCMID

June 1, 2023

33rd ECCMID. Copenhagen, Denmark

 

Several members of the THOP-GHTM research group attended the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) between 15th and 18th of April, that took place as a hybrid event both online and in Copenhagen, Denmark.

This year´s edition of ECCMID had the participation of nearly 16,000 attendees from 146 countries and included symposiums, workshops, oral and poster presentations about the most recent findings in clinical microbiology and infectious diseases around the world.

THOP-GHTM Research Group members attendeding ECCMID 2023 onsite

GHTM participation at this congress, online and onsite, involved the GHTM coordinator, Miguel Viveiros, the GHTM-THOP group coordinator Isabel Couto, the THOP researchers Sofia Santos Costa, Liliana Rodrigues and Ana Armada and PhD students Catarina Morais, Marcelino Garrine and Carolina Ferreira, the last four with financial support provided by GHTM.

During the event, the GHTM members presented seven posters and one flash-poster presentation, about the work developed in GHTM/IHTM-NOVA. The studies presented covered topics from S. aureus molecular epidemiology in Mozambique to drug susceptibility, resistance mechanisms and drug repurposing in Staphylococcus, Escherichia coli, macrophage microbicidal responses against Borrelia burgdorferi s.l. and to recent advances in the diagnosis of leptospirosis and Mycoplasma genitalium.

ECCMID 2023: this photo shows Ana Armada during her flash-poster presentation

Ana Armada presented a flash-poster on the antimicrobial mechanisms employed by macrophages exposed to pathogenic spirochetes responsible for Lyme borreliosis and a poster about the optimization and application of an indirect immunofluorescence test for the diagnosis of leptospirosis in conventional laboratories.

ECCMID 2023: this photo shows Sofia Santos Costa during her Poster presentation

Sofia Santos Costa presented a poster about drug repurposing for identification of new efflux inhibitors and/or antibiofilm agents against Staphylococcus aureus and Staphylococcus epidermidis.

Liliana Rodrigues presented two posters about her work on the evaluation of the activity of repurposed drugs against E. coli and on the molecular diagnosis and characterization of drug resistance of M. genitalium.

Marcelino Garrine presented a poster on the antimicrobial resistance and molecular epidemiology of S. aureus causing bacteremia in children under 5 years-old in Mozambique.

ECCMID 2023: this photo shows Catarina Morais during her Poster presentation

Catarina Morais presented a poster about the assessment of chlorohexidine activity against Staphylococcus aureus and Staphylococcus pseudintermedius from skin and soft-tissue infections in companion animals.

ECCMID 2023: this photo shows Carolina Ferreira during her Poster presentation

Carolina Ferreira presented a poster about the occurrence and variability of norA and other main multidrug efflux pump determinants across the Staphylococcus genus.

The 34th ECCMID will take place in Barcelona between 27th and 30th of April 2024.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

 

Loading Comments...
 

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok